Provided by Tiger Trade Technology Pte. Ltd.

Creative Medical Technology Holdings, Inc.

0.8600
+0.03804.62%
Volume:161.47K
Turnover:139.31K
Market Cap:5.67M
PE:-0.44
High:0.8967
Open:0.8600
Low:0.8289
Close:0.8220
52wk High:6.25
52wk Low:0.6200
Shares:6.59M
Float Shares:6.33M
Volume Ratio:0.89
T/O Rate:2.55%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.9543
EPS(LYR):-2.5200
ROE:-77.88%
ROA:-47.32%
PB:0.66
PE(LYR):-0.34

Loading ...

Creative Medical files to sell 3.05M shares of common stock

TIPRANKS
·
Jun 26

Creative Medical expands ADAPT trial under new FDA clearance

TIPRANKS
·
Jun 22

Creative Medical wins FDA clearance to expand ADAPT trial of Olastrocel in chronic lower back pain

Reuters
·
Jun 22

Creative Medical Technology Holdings Expands Adapt Trial Under New FDA Clearance and Rapidly Advances Toward Phase 3 Planning for Olastrocel in Chronic Lower Back Pain

THOMSON REUTERS
·
Jun 22

Creative Medical Technology Holdings Expands ADAPT Trial Under New FDA Clearance and Rapidly Advances Toward Phase 3 Planning for Olastrocel in Chronic Lower Back Pain

GlobeNewswire
·
Jun 22

Creative Medical advances Project PHOENIX burn pit exposure registry into nationwide AI-driven virtual data collection phase

Reuters
·
Jun 16

Creative Medical Technology Holdings, Inc. Advances Project PHOENIX into Nationwide AI Driven Virtual Data Collection Phase for U.S. Veterans Exposed to Burn Pits and Toxic Hazards

GlobeNewswire
·
Jun 16

Creative Medical Tech Q1 EPS $(0.38) Beats $(0.39) Estimate

Benzinga Earnings
·
May 09

Creative Medical Technology Holdings Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 09

Creative Medical net loss narrows 14.31% to $1.4 million in Q1 FY26

Reuters
·
May 09

Creative Medical Technology Holdings Inc expected to post a loss of 39 cents a share - Earnings Preview

Reuters
·
May 06

Creative Medical knee data ‘highly positive,’ says Roth Capital

TIPRANKS
·
Apr 28

Creative Medical reports pilot study of Ultrasome meets priamry endpoint

TIPRANKS
·
Apr 28

Creative Medical Technology Holdings, Inc. Reports Breakthrough 93% Response Rate in Ultrasome™ Knee Osteoarthritis Program, Expanding CELZ-201 Platform into Scalable Cell-Free Regenerative Therapies

GlobeNewswire
·
Apr 28